oral semaglutide news improves blood sugar, weight, and liver markers in real-world diabetes care What's New | Scaling Skinny

For stakeholders across healthcare, the challenge is clear: keep ahead of the obesity market changes, adapt strategies, and seize opportunities in this rapidly evolving landscape

Modulatory influence of Adhatodavesica leaf extract on the enzymes of xenobiotic metabolism, antioxidant status and lipid peroxidation in mice

From the perspective of prolactin: a view on obesity

Real-world evidence from UK and European databases suggests that patients with type 2 diabetes and fatty liver who receive GLP-1 therapy experience improvements in liver enzyme levels (ALT, AST) and non-invasive markers of fibrosis

Absolutely, big names like Venistro Nutralife are in on the global export game too.